Table 3.
The analysis of sensitivity, specificity, and accuracy for assessment of myometrial invasion in MRI.
| Total Cohorts | Pathology | |||
|---|---|---|---|---|
| Positive | Negative | Total | ||
| MRI | Positive | 125 (47.5%) | 49 (18.6%) | 174 (66.2%) |
| Negative | 46 (17.4%) | 43 (16.3%) | 89 (33.8%) | |
| Total | 171 (65.0%) | 92 (35.0%) | 263 (100%) | |
| Group 1 | Pathology | |||
| Positive | Negative | Total | ||
| MRI | Positive | 15 (45.5%) | 6 (18.2%) | 21 (63.6%) |
| Negative | 8 (24.2%) | 4 (12.1%) | 12 (36.3%) | |
| Total | 23 (69.7%) | 10 (30.3%) | 33 (100%) | |
| Group 2 | Pathology | |||
| Positive | Negative | Total | ||
| MRI | Positive | 15 (41.7%) | 9 (25.0%) | 24 (66.7%) |
| Negative | 9 (25.0%) | 3 (8.3%) | 12 (33.3%) | |
| Total | 24 (66.7%) | 12 (33.3%) | 36 (100%) | |
| Group 3 | Pathology | |||
| Positive | Negative | Total | ||
| MRI | Positive | 19 (41.3%) | 12 (26.1%) | 31 (67.4%) |
| Negative | 4 (8.7%) | 11 (23.9%) | 15 (32.6%) | |
| Total | 23 (50.0%) | 23 (50.0%) | 46 (100%) | |
| Group 4 | Pathology | |||
| Positive | Negative | Total | ||
| MRI | Positive | 69 (51.5%) | 19 (14.2%) | 88 (65.7%) |
| Negative | 22 (16.4%) | 24 (17.9%) | 46 (34.3%) | |
| Total | 91 (67.9%) | 43 (32.1%) | 134 (100%) | |